Epic Sciences Expands Leadership Team to Address Liquid Biopsy Demand
/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...
Stay updated with breaking news from Epic Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...
Cancer is not an easy target. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined malignancies without lethality over the average lifespan.
Share this article Share this article ResearchAndMarkets.com's offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populat...
Research and Markets: Global Clinical Laboratory Developed Tests (LDT) Services and Supplies Market Report 2020 - ResearchAndMarkets.com ResearchAndMarkets.com's offering. In this report, laboratory developed tests (LDTs) include all clinical tests developed by laboratories for their own use, in contrast to in vitro diagnostic (IVD) kits that are manufactured and sold by diagnostic companies for use by many different clinical labs. Clinical laboratories can develop LDTs based on any diagnostic test technology used in the clinical lab. For some technologies, such as chemistry tests or immunoas...